Evidence map›Paper›PMID 31996445›Full record

ArticleJournal of clinical microbiology2020

Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of

Helio S Sader, Paul R Rhomberg, Sukantha Chandrasekaran, Marisol Trejo, Kelley A Fedler, Linda D Boyken, Daniel J Diekema

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Ceftazidime-avibactam activity againstIranian journal of microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Helio S SaderJMI Laboratories, North Liberty, Iowa, USA helio-sader@jmilabs.com.
Paul R RhombergJMI Laboratories, North Liberty, Iowa, USA.
Sukantha ChandrasekaranUniversity of California, Los Angeles, Los Angeles, California, USA.
Marisol TrejoUniversity of California, Los Angeles, Los Angeles, California, USA.
Kelley A FedlerJMI Laboratories, North Liberty, Iowa, USA.
Linda D BoykenUniversity of Iowa, Iowa City, Iowa, USA.
Daniel J DiekemaUniversity of Iowa, Iowa City, Iowa, USA.
JMI Laboratories · USUniversity of California, Los Angeles · USUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed the ceftazidime-avibactam disk diffusion breakpoints that provide the lowest discrepancy error rates by testing an

Indexed as

Anti-Bacterial AgentsPseudomonas aeruginosaAzabicyclo CompoundsCeftazidimeDrug CombinationsHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsCeftazidimeDrug Combinationsceftazidime-avibactamCREdisk diffusionEnterobacteriaceaeKPC

Identifiers

PMID31996445
PMCPMC7098758
OpenAlexW3003777328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.